TOI
The Oncology Institute, Inc.
NASDAQ · USHealthcareMedical - Care Facilities
$5.50+2.80%
Price as of Jul 20, 2026
TOI financials
The Oncology Institute, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $502.7M | $393.4M | $324.2M | $252.5M |
| Cost of revenue | $426.3M | $339.4M | $264.7M | $200.4M |
| Gross profit | $76.4M | $54.0M | $59.6M | $52.1M |
| Operating expenses | $112.5M | $114.1M | $136.6M | $134.0M |
| Operating income | -$36.1M | -$60.1M | -$77.0M | -$82.0M |
| Net income | -$60.6M | -$64.7M | -$83.1M | $152.0K |
| EBITDA | -$42.5M | -$50.9M | -$54.3M | -$67.6M |
| Basic EPS | $-0.54 | $-0.71 | $-0.92 | $0.00 |
| Diluted EPS | $-0.54 | $-0.71 | $-0.92 | $-0.21 |
| Balance sheet | ||||
| Cash & equivalents | $33.6M | $49.7M | $33.5M | $14.0M |
| Total assets | $164.7M | $172.7M | $209.2M | $261.7M |
| Total liabilities | $180.4M | $169.1M | $152.2M | $138.5M |
| Stockholders’ equity | -$15.7M | $3.6M | $57.0M | $123.2M |
| Total debt | $103.7M | $123.2M | $119.7M | $108.2M |
| Net debt | $70.1M | $73.5M | $86.2M | $94.2M |
| Cash flow | ||||
| Operating cash flow | -$24.6M | -$26.5M | -$36.3M | -$61.8M |
| Capital expenditure | -$3.2M | -$3.8M | -$4.6M | -$5.5M |
| Free cash flow | -$27.8M | -$30.3M | -$40.9M | -$67.3M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | -$1.0M | -$9.0M |